Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Speaking Engagement Conference/Convention

LSX World Congress 2021

Tuesday, February 2nd, 2021

Speaking Engagement Conference/Convention

LSX World Congress 2021

Tuesday, February 2nd, 2021, 9:00 am GMT

​Fish attorney Teresa Lavoie (Twin Cities) will speak on the “If I Had Known Then What I Know Now – Best Practices For Entering The US Market” panel at LSX World Congress Virtual on Thursday, February 4, 2021.

LSX World Congress gathers the founders and CEOs of innovative start-ups through to publicly listed life sciences giants, and everyone in between. It represents the breadth and depth of the cutting-edge research and technology driving the advances in the industry right now and in the near future. Details for Teresa’s panel are below.

Thursday, February 4, 2021
10:00 – 11:00 AM BST

“If I Had Known Then What I Know Now” – Best Practices For Entering The US Market

Whether it’s patent strategy, working with potential investors or partners, or navigating the regulatory framework, what lessons can be learned from successful market entrants? And what pitfalls can companies avoid as they approach this major milestone in their development? This session will bring a broad range of perspectives from those who have experienced the challenges first-hand – companies that have successfully entered the market and those who have advised or funded companies doing the same. The group discusses preparing a patent portfolio for US clinical development, approval, and market entry, driving IP opportunities and value based on clinical and regulatory insights and coordinating clinical development and IP portfolio development.

  • Perspectives from the European and US sides of a company who have entered the US market
  • Key success factors from a seasoned entrepreneur who
  • Investor insight on preparation for entering the US

Moderator: Teresa Lavoie, Principal, Fish & Richardson

Panelists:

  • Darrin Disley, CEO, Mogrify
  • Nanna Lüneborg, Partner, Novo Ventures

Click here to learn more.